Start Date
May 31, 2020
Primary Completion Date
February 28, 2021
Study Completion Date
February 28, 2021
Prasterone
Nightly intravaginal prasterone insert (6.5 mg prasterone at a concentration of 0.50%) for 24 weeks.
Placebo
Nightly intravaginal placebo insert (Witepsol H-15, a mix of synthetic triglycerides) for 24 weeks.
University of Louisville Urogynecology at Springs Medical Center, Louisville
Collaborators (1)
AMAG Pharmaceuticals, Inc.
INDUSTRY
Olivia Cardenas-Trowers, M.D.
OTHER